Stay updated on Immunogenic Nivolumab + Ipilimumab in Prostate Cancer Clinical Trial
Sign up to get notified when there's something new on the Immunogenic Nivolumab + Ipilimumab in Prostate Cancer Clinical Trial page.

Latest updates to the Immunogenic Nivolumab + Ipilimumab in Prostate Cancer Clinical Trial page
- Check5 days agoChange DetectedAdded page revision note: Revision: v3.4.3. Removed Prostate cancer-related topics including MedlinePlus Genetics (Revision: v3.4.2).SummaryDifference0.2%

- Check12 days agoChange DetectedAdded 'Prostate cancer' as a topic and included a link to the MedlinePlus Genetics resource under related topics.SummaryDifference0.2%

- Check19 days agoChange DetectedRemoved the Prostate cancer topic and the MedlinePlus Genetics related topic from the page.SummaryDifference0.2%

- Check27 days agoChange DetectedAdded related topics sections for Prostate cancer and MedlinePlus Genetics, serving as navigation/context rather than core study content. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.2%

- Check34 days agoChange DetectedRevision: v3.4.2 was added, and the notice about government funding (and the prior Revision: v3.4.1) was removed.SummaryDifference0.5%

- Check41 days agoChange DetectedAdded a site-wide notice about a lapse in government funding and updated operation status guidance, including links to cc.nih.gov and opm.gov. Updated the page revision to v3.4.1, replacing v3.4.0.SummaryDifference0.5%

Stay in the know with updates to Immunogenic Nivolumab + Ipilimumab in Prostate Cancer Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Immunogenic Nivolumab + Ipilimumab in Prostate Cancer Clinical Trial page.